Het wordt 'steeds realistischer' dat de samenwerking tussen Jordan Henderson en Ajax beperkt blijft tot een half seizoen. Dat beeld schetst het Algemeen Dagblad, dat het huwelijk tussen de twee ...
Het is een begrijpelijke beslissing van de Engelse bondscoach Gareth Southgate om Jordan Henderson niet op te nemen in zijn ...
A fifth-place finish is Ajax’s only route into Europe next season, and they would still be required to go through the qualifying round to earn a place in the group stage of the 2024/25 Europa ...
Recent reports suggest that Jordan Henderson's tenure at Ajax hangs in the balance as the club grapples with financial constraints. Henderson, the former captain of Liverpool, made a move to the ...
Jordan Henderson's future at Ajax is already in doubt after the club failed to qualify for the Champions League for the second season in a row. The Dutch giants are lie in fifth place in the ...
De toekomst van Jordan Henderson bij Ajax is erg onzeker, zo melden The Athletic en Voetbal International vrijdagmiddag. Het mislopen van de Champions League - en mogelijk ook de Europa League ...
JORDAN HENDERSON'S future at Ajax is in doubt with the club needing to cut costs, according to reports. The former Liverpool captain joined the Dutch giants in January after a nightmare six months ...
The future of Jordan Henderson has been cast in doubt with Ajax considering cashing in on the England midfielder as the club face not playing in the Champions League Get the latest football news ...
The futures of Ajax players such as Jordan Henderson and Steven Bergwijn have been cast into doubt as the club count the cost of missing out on Champions League qualification for the second ...
Jordan Henderson looked emotional as he was given a standing ovation in what may be his final home game as an Ajax player. The 33-year-old continued his return to full fitness ahead of the Euro ...
NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs ...